Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Your Environment. Your Health.

Publication Detail

Title: 2-Aminopurine overrides multiple cell cycle checkpoints in BHK cells.

Authors: Andreassen, P R; Margolis, R L

Published In Proc Natl Acad Sci U S A, (1992 Mar 15)

Abstract: BHK cells blocked at any of several points in the cell cycle override their drug-induced arrest and proceed in the cycle when exposed concurrently to the protein kinase inhibitor 2-aminopurine (2-AP). For cells arrested at various points in interphase, 2-AP-induced cell cycle progression is made evident by arrival of the drug-treated cell population in mitosis. Cells that have escaped from mimosine G1 arrest, from hydroxyurea or aphidicolin S-phase arrest, or from VM-26-induced G2 arrest subsequently have all the hallmarks of mitosis--such as a mitotic microtubule array, nuclear envelope breakdown, and chromatin condensation. In a synchronous population, the time course of arrival in mitosis and its duration in 2-AP-treated cells that have escaped drug-induced cell cycle blocks is indistinguishable from control cells. Cells arrested in mitosis by nocodazole or taxol quickly escape mitotic arrest and enter interphase when exposed to 2-AP. 2-AP by itself does not influence the timing of cell cycle progression. We conclude that 2-AP acts to override checkpoints in every phase of the cell cycle, perhaps by inhibiting a protein kinase responsible for control of multiple cell cycle checkpoints.

PubMed ID: 1549593 Exiting the NIEHS site

MeSH Terms: 2-Aminopurine/pharmacology*; Animals; Aphidicolin/pharmacology; Cell Cycle/drug effects*; Cell Line; Cricetinae; DNA/analysis; Flow Cytometry; G1 Phase/drug effects; G2 Phase/drug effects; Hydroxyurea/pharmacology; Kidney; Kinetics; Microtubules/drug effects; Microtubules/ultrastructure; Mimosine/pharmacology; Mitotic Index; Protein Kinase Inhibitors; Teniposide/pharmacology; Time Factors

to Top